Autoregulation of serotonin neurons: role in antidepressant drug action G Piñeyro, P Blier Pharmacological reviews 51 (3), 533-591, 1999 | 715 | 1999 |
β-Arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors M Azzi, PG Charest, S Angers, G Rousseau, T Kohout, M Bouvier, ... Proceedings of the National Academy of Sciences 100 (20), 11406-11411, 2003 | 653 | 2003 |
Serotonin4 (5-HT4) receptor agonists are putative antidepressants with a rapid onset of action G Lucas, VV Rymar, J Du, O Mnie-Filali, C Bisgaard, S Manta, ... Neuron 55 (5), 712-725, 2007 | 397 | 2007 |
Role of Somatodendritic 5‐HT Autoreceptors in Modulating 5‐HT Neurotransmissiona P Blier, G Pineyro, M El Mansari, R Bergeron, C De Montigny Annals of the New York Academy of Sciences 861 (1), 204-216, 1998 | 324 | 1998 |
Desensitization of the neuronal 5-HT carrier following its long-term blockade G Pineyro, P Blier, T Dennis, C de Montigny Journal of Neuroscience 14 (5), 3036-3047, 1994 | 234 | 1994 |
Bioluminescence resonance energy transfer assays reveal ligand-specific conformational changes within preformed signaling complexes containing δ-opioid receptors and … N Audet, C Galés, E Archer-Lahlou, M Vallières, PW Schiller, M Bouvier, ... Journal of Biological Chemistry 283 (22), 15078-15088, 2008 | 142 | 2008 |
Molecular pharmacology of δ-opioid receptors L Gendron, CM Cahill, M von Zastrow, PW Schiller, G Pineyro Pharmacological reviews 68 (3), 631-700, 2016 | 137 | 2016 |
Functional selectivity profiling of the angiotensin II type 1 receptor using pathway-wide BRET signaling sensors Y Namkung, C LeGouill, S Kumar, Y Cao, LB Teixeira, V Lukasheva, ... Science signaling 11 (559), eaat1631, 2018 | 135 | 2018 |
Regulation of [3H] 5-HT release in raphe, frontal cortex and hippocampus of 5-HT1B knock-out mice G Piñeyro, N Castanon, R Hen, P Blier Neuroreport 7 (1), 353-359, 1995 | 102 | 1995 |
5-HT1D receptors regulate 5-HT release in the rat raphe nuclei: In vivo voltammetry and in vitro superfusion studies G Piñeyro, C de Montigny, P Blier Neuropsychopharmacology 13 (3), 249-260, 1995 | 95 | 1995 |
Internalization and Src activity regulate the time course of ERK activation by delta opioid receptor ligands N Audet, M Paquin-Gobeil, O Landry-Paquet, PW Schiller, G Piñeyro Journal of Biological Chemistry 280 (9), 7808-7816, 2005 | 85 | 2005 |
Differential association of receptor-Gβγ complexes with β-arrestin2 determines recycling bias and potential for tolerance of delta opioid receptor agonists N Audet, I Charfi, O Mnie-Filali, M Amraei, AJ Chabot-Doré, M Millecamps, ... Journal of Neuroscience 32 (14), 4827-4840, 2012 | 76 | 2012 |
Kir3 channel signaling complexes: focus on opioid receptor signaling K Nagi, G Pineyro Frontiers in cellular neuroscience 8, 186, 2014 | 72 | 2014 |
Neurotensin triggers dopamine D2 receptor desensitization through a protein kinase C and β-arrestin1-dependent mechanism D Thibault, PR Albert, G Pineyro, LÉ Trudeau Journal of Biological Chemistry 286 (11), 9174-9184, 2011 | 71 | 2011 |
Simultaneous anhedonia and exaggerated locomotor activation in an animal model of depression T Romeas, MC Morissette, O Mnie-Filali, G Piñeyro, SM Boye Psychopharmacology 205, 293-303, 2009 | 71 | 2009 |
Ligand-specific receptor states: implications for opiate receptor signalling and regulation G Piñeyro, E Archer-Lahlou Cellular signalling 19 (1), 8-19, 2007 | 68 | 2007 |
Regulation of opioid receptor signalling: implications for the development of analgesic tolerance K Nagi, G Piñeyro Molecular Brain 4, 1-9, 2011 | 63 | 2011 |
5-HT receptor agonists 1-(2, 5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and 8-OH-DPAT increase wakefulness in the rat JM Monti, G Pineyro, C Orellana, M Boussard, H Jantos, P Labraga, ... Biogenic Amines 7 (2), 145-151, 1990 | 63 | 1990 |
Regulation of 5-hydroxytryptamine release from rat midbrain raphe nuclei by 5-hydroxytryptamine1D receptors: effect of tetrodotoxin, G protein inactivation and long-term … G Piñeyro, P Blier Journal of Pharmacology and Experimental Therapeutics 276 (2), 697-707, 1996 | 59 | 1996 |
Conformational dynamics of Kir3. 1/Kir3. 2 channel activation via δ-opioid receptors M Richard-Lalonde, K Nagi, N Audet, R Sleno, M Amraei, M Hogue, ... Molecular pharmacology 83 (2), 416-428, 2013 | 58 | 2013 |